This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Oncology  • Cervical Cancer  • World Health  • Women's Health  • Women's Health, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Denny and colleagues¹ reported the safety and efficacy of a resource-appropriate approach for cervical cancer screening designed for less-developed countries. This is important because although cervical cancer incidence has decreased significantly in recent decades in economically developed countries, it has remained a major social and economic burden in low-resource countries.²

The introduction of appropriate screening methods and strategies available for low-income women and low-resource countries has become an important challenge in terms of safety, efficacy, and cost-effectiveness in Hungary, which is considered to have a transitional or developing economy. The National Health Insurance Fund Administration, the health care financing agency in Hungary, conducted a cost-effectiveness analysis of cervical cancer screening (including cytologic testing and colposcopy).³ Although the cost per life-year saved was considered to be acceptable, it remained necessary to analyze the budget impact of such a screening program.

We compared the 2001 national treatment cost . . . [Full Text of this Article]

Imre Boncz, MD, MSc
boncz.i@oep.hu
Department of Health Policy
National Health Insurance Fund Administration
Budapest, Hungary

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?